Tumors can harm the human metabolic system in several ways. To better understand how this can be prevented, a group of scientists from Hangzhou Normal University in China, whose work was published in the Journal of Chromatography A, investigated a new means of measuring aberrant metabolites (1).
Tumor cells rely on metabolic reprogramming, which involves several processes such as fatty acids syntheses and glutaminlysis, to reduce stress necessary for survival. This has led into extensive research into metabolic reprogramming and the creation of various treatments. Common techniques, such as liquid chromatography-mass spectrometry (LC–MS) and gas chromatography-mass spectrometry (GC–MS), have been ineffective in this process due to strong polarities, isomerism, or low ionization efficiencies during MS detection. However, chemical derivatization of metabolites may prove to be a more effective method for metabolic reprogramming.
Epoxydocosapentaenoic acids (EDPs) derived from omega-3 fatty acids can slow down blood vessel creation and endothelial cells’ movements, while phosphoglycerate dehydrogenase (PHGDH) was discovered to impede the production of nucleotides from glycolytic serine, a critical source of single carbons in breast cancer. These metabolic vulnerabilities can pave the way for more effective means of combatting tumor cells by helping identify them quicker.
Chemical derivatization is a promising field, and there seems to be more room to grow with how these techniques can be used. In the future, these methods may be able to impact how medical professionals can detect and combat tumor growth can change and grow to be more effective than previously thought.
(1) Advancements in Analyzing Tumor Metabolites through Chemical Derivatization-Based Chromatography. J. Chromatogr. A. 2023, 1706, 464236. DOI: https://doi.org/10.1016/j.chroma.2023.464236
TD-GC–MS and IDMS Sample Prep for CRM to Quantify Decabromodiphenyl Ether in Polystyrene Matrix
April 26th 2024At issue in this study was the certified value of decabromodiphenyl ether (BDE 209) in a polystyrene matrix CRM relative to its regulated value in the EU Restriction of Hazardous Substances Directive.
LC–MS/MS-Based System Used to Profile Ceramide Reactions to Diseases
April 26th 2024Scientists from the University of Córdoba in Córdoba, Spain recently used liquid chromatography–tandem mass spectrometry (LC–MS/MS) to comprehensively profile human ceramides to determine their reactions to diseases.
High-Throughput 4D TIMS Method Accelerates Lipidomics Analysis
April 25th 2024Ultrahigh-pressure liquid chromatography coupled to high-resolution mass spectrometry (UHPLC-HRMS) had been previously proposed for untargeted lipidomics analysis, but this updated approach was reported by the authors to reduce run time to 4 min.